Medicure Inc. (OTCMKTS:MCUJF) Sees Significant Increase in Short Interest

Medicure Inc. (OTCMKTS:MCUJFGet Free Report) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 1,500 shares, a growth of 650.0% from the February 28th total of 200 shares. Based on an average trading volume of 6,900 shares, the short-interest ratio is presently 0.2 days. Approximately 0.0% of the company’s shares are short sold.

Medicure Stock Performance

Shares of Medicure stock remained flat at $0.46 during trading on Thursday. The firm has a market capitalization of $4.75 million, a PE ratio of -3.25 and a beta of 0.87. The company has a quick ratio of 1.64, a current ratio of 2.03 and a debt-to-equity ratio of 0.03. Medicure has a twelve month low of $0.46 and a twelve month high of $0.92. The business has a 50-day simple moving average of $0.52 and a two-hundred day simple moving average of $0.62.

About Medicure

(Get Free Report)

Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.

Further Reading

Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.